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EDITORIAL
Chemokines, chemokine receptors and renal disease
gesting that, at least in this model, MCP-1 promotedChemokines are proinflammatory cytokines that func-
nearly exclusively tubular epithelial cell damage [5].tion in leukocyte chemoattraction and activation. There
Contrasting with the ample information about chemo-are two major families of chemokines, termed CXC and
kines and renal injury, so far, little is known about theCC, according to the presence or absence of an amino
expression and distribution of chemokine receptors onacid between a pair of cysteine residues near the NH2
different cells in normal and diseased kidneys. In thisterminal [1, 2]. CXC chemokines [of which interleukin-8
issue of Kidney International, Segerer et al studied, by(IL-8) is the prototype] act on neutrophils and nonhemo-
means of monoclonal antibodies, the distribution ofpoietic cells involved in wound healing, whereas CC che-
CCR5 (that binds to RANTES, MIP-1 and MIP-1b, butmokines have a wider spectrum of action and they are
not MCP-1) in 80 biopsies from patients with variousactive on monocytes, T and B lymphocytes, natural killer
glomerulonephritis, acute and chronic interstitial nephri-(NK) cells and dendritic cells, and they are, therefore,
tis, and acute and chronic transplant rejection [6]. Theof great relevance in renal disease [3]. Monocytes and
most striking finding was that staining for CCR5 wastissue macrophages are rich sources of CC chemokines,
only detected in areas of interstitial infiltrating cells withusually associated with de novo synthesis. Monocyte che-
the same distribution as CD3-positive T cells. Absence ormoattractant protein-1 (MCP-1) and MCP-2 are major
near absence of staining for CCR5 in infiltrating CD-68products of stimulated monocytes. Lymphocytes are
positive macrophages, and in intrinsic renal cells, weresources of some chemokines, particularly RANTES,
noted in nearly all the kidney diseases examined. Themacrophage inflammatory protein-1 (MIP-1) and MIP-1b.
lack of CCR5 expression by monocytes/macrophages inEndothelial cells, fibroblasts, epithelial cells and other
the glomerulonephritis studied, mainly systemic lupuskidney cells also produce CC chemokines after appro-
erythematosus (SLE), was unexplained. However, it couldpriate stimuli. Chemokines act through interaction with
be speculated that other chemokines besides RANTES,seven transmembrane domain G-coupled receptors. So
such as MCP-1, released by glomerular and tubular cellsfar, nine receptors have been identified for the CC che-
during renal injury, may be responsible for the recruit-mokines (CCR1 to -9), and four for the CXC chemokines
ment of macrophages. In fact, various CC and CXC(CXCR1 to -4). Chemokine receptors show a promiscu-
chemokines may be released during glomerular damage.ous pattern of ligand recognition and are differentially
In addition, there are at least three monocyte CC chemo-expressed and regulated in leukocytes [1, 2].
kine receptors (CCR1, CCR2 and CCR5). One can as-The glomerular and interstitial infiltration of leuko-
sume that CCR5-negative infiltrating cells, both at thecytes is a common phenomenon found in most renal dis-
glomerular and interstitial level, should be positive foreases, independently of their immune or non-immune
other chemokine receptors, most probably CCR2. In thisorigin. MCP-1 and RANTES are the most studied che-
regard, mice deficient in CCR2 have severe reduction inmokines implicated in renal damage [3]. The importance
leukocyte adhesion and monocyte extravasation afterof MCP-1 and RANTES in anti-GBM nephritis was sup-
intraperitoneal thioglycollate injection, indicating thatported by the reduction of glomerular damage after block-
CCR2, after its stimulation by MCP-1, is a major regula-ade of those chemokines by specific antibodies and recep-
tor of macrophage trafficking in vivo.tor antagonists. However, although both chemokines seem
The mechanisms that regulate expression of the che-to participate in glomerular inflammation, only MCP-1
mokine receptors are not well defined, but it is wellwas related to the crescentic and fibrogenic process, sug-
known that cytokines can modify the density of receptorsgesting that MCP-1 could also be involved in the turn-
in a particular cell. Thus, IL-2 increases the CCR1 andover of matrix proteins [4]. Surprisingly, MCP-1 deficient
CCR2 expression, as well as the chemotactic respon-mice injected with nephrotoxic serum had a marked re-
siveness, in T lymphocytes. Lipopolysaccharide down-duction in tubular, but not in glomerular, injury, sug-
regulates the expression of CCR2 in cultured monocytes,
mostly due to the rapid degradation of CCR2 mRNA.
Those cells are unresponsive to MCP-1 (which activatesKey words: leukocytes, wound healing, anti-GBM nephritis, renal
damage. only CCR2), but they remain responsive to MIP 1 (which
activates CCR1 and CCR5). An up-regulation of CCR1 1999 by the International Society of Nephrology
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and CCR3, as well as induction of chemotaxis to CC kine receptors that can be regulated both in vitro and
in vivo. The absence of CCR5 expression in human renalchemokines, was elicited by interferon-g (IFN-g) in hu-
man neutrophils. By contrast, IFN-g, an inducer of cells and its presence in cells of the central nervous sys-
tem suggest that the existence of some chemokine recep-MCP-1 and MCP-3 in mononuclear phagocytes, selec-
tively inhibits expression of the MCP-1 receptor CCR2 tors could be organ dependent.
Additional studies, focusing on the expression (genein monocytes [7]. These results are consistent with an
emerging paradigm of divergent regulation of chemo- and protein) of other chemokine receptors in normal
and diseased kidneys, as well as a better understandingkine production and receptor expression in monocytes
by several agents. The inhibition of CCR2 expression of their respective roles, are necessary for further insight
into the complicated network involving leukocyte at-may serve as a means of retaining mononuclear cells at
inflammation site, and as a feedback mechanism in the traction in immune and non-immune renal diseases. This
could provide new molecular targets for therapeutic in-regulation of cell recruitment from the blood. Low den-
sity lipoprotein has also been identified as a positive tervention in kidney diseases.
regulator of CCR2 expression [8], and this could be one
Jesu´s Egidoof the mechanisms contributing to monocyte recruitment
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Another intriguing observation of Segerer et al was
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